82 FR 248 pgs. 61573-61574 - Healthcare Infection Control Practices Advisory Committee (HICPAC)
Type: NOTICEVolume: 82Number: 248Pages: 61573 - 61574
Pages: 61573, 61574FR document: [FR Doc. 2017-28072 Filed 12-27-17; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee (HICPAC)
AGENCY:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice of meeting.
SUMMARY:
[top] In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is open to the public, limited only by audio phone lines available. The public is also welcome to listen to the meeting by
DATES:
The meeting will be held on February 15, 2018, 12:00 p.m. to 2:00 p.m., EST.
ADDRESSES:
Teleconference Number: 888-946-7207, passcode: 5023213
FOR FURTHER INFORMATION CONTACT:
Erin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop A-31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include discussions from the recommendation categorization update workgroup, the guidelines for infection prevention in healthcare personnel workgroup, and the guidelines for infection prevention in patients of neonatal intensive care units workgroup. Agenda items are subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2017-28072 Filed 12-27-17; 8:45 am]
BILLING CODE 4163-19-P